Multi-Centre, Retrospective, Open Label Study, to Validate ML-PrediCare by Patients With Melanoma Under 1st and 2nd Lines of Immunotherapy
Clinical trial NCT02581228 · UNKNOWN
Trial details
- NCT number
- NCT02581228
- Sponsor
- Optimata Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-04-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.